We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 282 start-ups with an aggregate funding of $11.6b. The average funding per company in this subset is $167.4m.
Last update to the database: Feb 18, 2025. See changelog.
5
Funding Rounds
$5.1m
Money raised
Indee Labs focuses on the development of microfluidic vortex shedding for rapidly and efficiently transfecting human primary immune cells with negligible perturbation. The team is focused on developing its core technology for short turnaround chimeric antigen receptor T cell (CAR-T) development and manufacturing.
5
Funding Rounds
$390.0m
Money raised
PathAI is a Boston-based artificial intelligence company developing therapeutics and healthcare products.
10
Funding Rounds
$930.0m
Money raised
Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare.
1
Funding Rounds
$25.3m
Money raised
Leo Cancer Care is a company developing upright radiotherapy solutions.
4
Funding Rounds
$1.8b
Money raised
Grail is a biotechnology company headquartered in Menlo Park, California that was founded as a spinoff of Illumina Inc and initially headed by Jeffrey Huber in 2016, focused on making a medical device that can detect early stage cancer.
8
Funding Rounds
$71.3m
Money raised
Notable Labs is a company providing personalized drug combination testing service for cancer patients.
2
Funding Rounds
$158.0m
Money raised
Senti Biosciences is a synthetic biology company.
6
Funding Rounds
$399.8m
Money raised
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
3
Funding Rounds
$313.0m
Money raised
Flatiron Health is a startup that organizes real-time oncology data to help cancer patients and doctors.
10
Funding Rounds
$410.0m
Money raised
Paige provides AI-based digital diagnostics and a vendor-neutral platform designed to drive diagnostic confidence and a more productive pathology workflow.
6
Funding Rounds
$190.5m
Money raised
Kuur Therapeutics focuses on the development of CAR-NKT cell therapies platform for applications in cancer treatment.
6
Funding Rounds
$15.8m
Money raised
Massive Bio is a New York-based company founded by Selin Kurnaz, Dr. Arturo Loaiza-Bonilla and Cagatay M. Culcuoglu, offering precision oncology services to cancer patients, providers, and pharmaceutical companies.
2
Funding Rounds
$13.8m
Money raised
A biopharmaceutical company developing therapeutics to attack cancer stem cells.
4
Funding Rounds
$140.0m
Money raised
Mission Bio is a South San Francisco based company that develops single-cell DNA analysis and precision genomics.
3
Funding Rounds
$31.2m
Money raised
Deep Lens is an Artificial Intelligence company matching patients with clinical trials.
2
Funding Rounds
$164.5m
Money raised
Develops novel cell and gene therapies with pharmacologic operating systems.
8
Funding Rounds
$967.6m
Money raised
Freenome is a San Francisco-based company which uses genetic analysis for early cancer detection and risk assessment.
2
Funding Rounds
$67.5m
Money raised
A company developing immunotherapy treatments for cancers, infectious and autoimmune diseases
5
Funding Rounds
$155.6m
Money raised
Athelas is a company developing blood testing device that utilizes deep learning and computer vision.
2
Funding Rounds
$18.1m
Money raised
A biotechnology company that develops treatments for cancer and hematologic conditions
4
Funding Rounds
$743.2m
Money raised
A bioinformatics company in San Francisco building data collection methods and databases that will enable machine learning algorithms in healthcare. It was founded in 2018.
3
Funding Rounds
$52.0m
Money raised
3T Biosciences is a biotechnology company developing immunotherapies.
7
Funding Rounds
$65.4m
Money raised
Mendel.ai is a life science company offering an artificial intelligence platform to aid clinical experts improve their clinical cancer research.
4
Funding Rounds
$7.1m
Money raised
Oisin develops anti-aging treatments that target and remove senescent cells, a type of damaged cell that is unable to divide, accumulates during aging and contribute to age-related diseases.
8
Funding Rounds
$160.3m
Money raised
Breathalyzer device maker for the early detection of cancer.
1
Funding Rounds
$77.0m
Money raised
MiRXES is a Singapore-based biotechnology company specializing in microRNA-based diagnostics founded in 2014.
5
Funding Rounds
$425.0m
Money raised
Tmunity Therapeutics is a biotechnology company developing t-cell immunotherapies for the treatment of human diseases.
3
Funding Rounds
$67.0m
Money raised
Faeth Therapeutics is a start-up that focuses on using nutrition and metabolism to fight cancer.
2
Funding Rounds
$11.5m
Money raised
An artificial intelligence company with a focus on developing solutions for the healthcare industry. It was founded in 2017 and is located in Tel Aviv, Israel.
4
Funding Rounds
$96.5m
Money raised
Foundation Medicine is a Cambridge, Massachusetts-based pharmaceutical company developing diagnostic and treatment solutions for cancer care founded in 2010 by Alexis Borisy.
1
Funding Rounds
$150.0k
Money raised
CaroGen is an immunotherapy company that develops vaccine candidates that target hepatitis B and C, as well as other viral agents.
5
Funding Rounds
$19.7m
Money raised
OncoSenX is a spinout company of Oisin Biotechnologies, formed to develop programmable suicide gene therapy to kill cancerous cells.
2
Funding Rounds
$58.4m
Money raised
ITM Isotopen Technologien Munchen is a Munich-based developer of personalized cancer diagnostic solutions.
2
Funding Rounds
$37.5m
Money raised
A biomedical company in United Kingdom that develops vaccines and vaccine development technology
2
Funding Rounds
$386.0m
Money raised
Focused on transforming lives of patients with immune dysfunctions and cancer
1
Funding Rounds
Stelvio Therapeutics is a biotechnology company developing therapeutics for cancer.
5
Funding Rounds
$26.0m
Money raised
DCPrime is a biotechnology company developing cancer immunotherapies.
2
Funding Rounds
$195.5m
Money raised
JW (Cayman) Therapeutics Co. Ltd is a Shanghai-based developer of cell-based therapy technologies for cancer treatment.
1
Funding Rounds
Biotechnology company founded in 2015 that develops and commercializes synthetic lipid compounds and cancer immunotherapy agents. iOx Therapeutics is an OSI spinout.
1
Funding Rounds
$2.0m
Money raised
A&G Pharmaceutical is a Columbia, Maryland-based theranostics company developing personalized cancer therapeutics through cancer-specific monoclonal antibodies.
2
Funding Rounds
$105.0m
Money raised
Eureka Therapeutics is a biotechnology company developing immunotherapies for the treatment of cancer.
3
Funding Rounds
$32.5m
Money raised
A pharmaceutical company developing tissue factor therapies for the treatment of cancer and diseases.
7
Funding Rounds
$195.5m
Money raised
Epic Sciences is a San Diego-based company founded in 2008 by Jorge Nieva, David Nelson and Peter Kuhn.
1
Funding Rounds
$80.0m
Money raised
A biotechnology company developing t-cell immunotherapies therapies for the treatment of cancer. The company is headquartered in Singapore, and was founded by Malcolm Brenner and Andrew Khoo in 2011.
1
Funding Rounds
$7.0m
Money raised
Gadeta is a biotechnology company developing immunotherapies for treating cancer.
1
Funding Rounds
$42.2m
Money raised
Soteria Biotherapeutics is a biotechnology company developing cancer immunotherapies.
4
Funding Rounds
$270.0m
Money raised
Small Molecules
1
Funding Rounds
$22.0m
Money raised
Biomedical Artificial Intelligence company developing products for early cancer detection in the breast.
3
Funding Rounds
$50.6m
Money raised
Cambridge, MA-based company developing targeted mRNA therapeutics for cancer and other diseases.
2
Funding Rounds
$33.8m
Money raised
A company developing immune therapies for cancer and related diseases
8
Funding Rounds
$59.9m
Money raised
MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up, created at the end of 2014, to treat diseases linked to imbalances in the intestinal microbiome.
1
Funding Rounds
$24.0m
Money raised
Gradalis is a drug manufacturer, and developer of vaccines, tools and diagnostics for the treatment of cancer.
6
Funding Rounds
$633.0m
Money raised
Caris Life Sciences is a medical diagnostics company developing molecular profiling combined with artificial intelligence founded in 1996 by David D. Halbert.
2
Funding Rounds
$112.0m
Money raised
Carisma Therapeutics is a biotechnology company founded in 2016 to bring the potheyr of adoptive cellular immunotherapy to solid tumor patients through a novel platform using chimeric antigen receptor macrophages (CARMA).
2
Funding Rounds
$33.9m
Money raised
Refuge Biotechnologies is a biotechnology company that uses CRISPR and cell therapy technologies for treating cancer.
2
Funding Rounds
$173.0k
Money raised
XEME Biopharma is a biotechnology company developing therapeutic cancer vaccines and cancer immunotherapy products.
6
Funding Rounds
$62.1m
Money raised
Crown bioscience is a company that is focused on research, drug discovery and development for the treatment of cancer and diabetes.
1
Funding Rounds
$32.0m
Money raised
A biotechnology company developing molecular-based diagnostic, prognostic, and predictive medical tests designed to help healthcare practitioners treat cancer.
6
Funding Rounds
$122.8m
Money raised
Canopy is a Draper, Utah-based company founded in 2014.
2
Funding Rounds
$2.6m
Money raised
Precision therapeutics company developing epigenetic therapies that target arginine methylation in cancer.
2
Funding Rounds
$8.1m
Money raised
SEngine Precision Medicine is a precision medicine company founded by Brady Bernard, Carla Grandori, Christopher Kemp, and VK Gadi.
5
Funding Rounds
$187.0m
Money raised
Iterative Health is a Cambridge, Massachusetts-based company that provides gastroenterologists with machine learning-powered diagnostic tools to aid in the prevention of colon cancer and improve patient outcomes.
2
Funding Rounds
$51.1m
Money raised
Heidelberg Pharma is a Ladenburg-based pre-clinical drug discovery and development company working on developing anti-cancer and anti-inflammatory drugs.
3
Funding Rounds
$200.0m
Money raised
PACT Pharma is synthesizing neo-epitope targeted T cells and producing a personalized adoptive cell therapy designed to benefit each cancer patient.
2
Funding Rounds
$128.2m
Money raised
HiberCell is a New York-based biotechnology company developing therapeutics to prevent relapse and metastasis.
3
Funding Rounds
$13.2m
Money raised
Biosceptre is a Cambridge, Cambridgeshire-based company developing diagnostic tools and biomarkers.
1
Funding Rounds
$35.0m
Money raised
Tactiva Therapeutics is a biotechnology company developing cancer immunotherapies.
3
Funding Rounds
$190.2m
Money raised
Cancer drugs that target specific types of poly ADP-ribose polymerase
5
Funding Rounds
$80.0m
Money raised
A diagnostics company focused on the discovery and development of diagnostic products for clinical laboratories for the management of oncology and genetic disorder.
Enter your email and get access to 71,000 + technology companies you can partner with.